吉隆坡：Bintai Kinden Corporation Bhd的合作伙伴Generex生物技术公司已为其li-Key疫苗申请了商标，并为其Ii-Key-SARS-CoV-2疫苗申请了专利。

Bintai Kinden在周四发表的一份声明中说，Ii-Key疫苗旨在作为Covid-19的完整疫苗。

它说：“该技术为快速开发Covid-19疫苗提供了最安全，最佳的途径。”

它解释了完整的疫苗旨在调节免疫系统，以提供有针对性的中和抗体反应。

Bintai Kinden董事总经理Ong Choon Lui表示，Generex的Covid-19疫苗是基于离体人体研究的结果。 将为一期和二期临床试验制定配方。

Generex的子公司NuGenerex Immuno-Oncology Inc正在探索将靶向Covid-19疫苗部署为RNA，DNA和灭活病毒疫苗的通用增强剂的机会，这些疫苗包含完整的刺突蛋白，并且有可能引发脱靶和过度活跃 免疫反应。

Bintai Healthcare Sdn Bhd获得Generex和NuGenerex的独家代理权，可在马来西亚，文莱，缅甸，柬埔寨，东帝汶，印度尼西亚，老挝，菲律宾，新加坡，泰国和越南分销，销售和商业化Covid-19疫苗。

它还获得了在澳大利亚，新西兰和全球清真市场内分销和销售疫苗的第一优先权。

https://www.generex.com/covid-19

if din limit up then just disappear from this forum and go promote another counter...."confirm" this word doesn't have any guarantee here if the promise is not accomplished. For any new comer here, think twice for the "confim" and check the person chat history before you trust his statement.

Who listen to me buy at 0.565 . Can Thank me ya. I already CL at 0.73
now Wait back at 0.60.
I rarely lie about the stock movement. (Handal Jaya Still have 16mil stock to dispose ) be ready to catch knife at the Hilt and not at the blade. P.S. Travel Video tyvm for ur luck worr.
Because Handal Jaya want to disposed thier Stock which was paid up for settlement of Bintai Debt to handal Jaya. 31,800,000 shares in total at 0.64 value for debt settlement.
So there will be 1 more round of disposal